Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.59
Price to sales ratio
0.65

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2322
NUTX
Nutex Health Inc. - Common Stock
179.15 USD-2.59%-6.98%+21.62%+40.34%1.23 B USD
2410
USPH
U.S. Physical Therapy, Inc. Common Stock
71.62 USD-1.24%-3.46%+9.43%-22.99%1.09 B USD
2932
CYH
Community Health Systems, Inc. Common Stock
3.48 USD-2.52%-5.69%+11.18%-7.45%490.39 M USD
3021
SRTA
Strata Critical Medical, Inc. - Class A Common Stock
5.01 USD-1.96%-7.22%-10.54%+14.12%433.50 M USD

Frequently asked questions about The Oncology Institute, Inc. - Common Stock

What is the The Oncology Institute, Inc. - Common Stock stock price today?

The current price of The Oncology Institute, Inc. - Common Stock (TOI) is 6.25. Over the past 24 hours, the stock has changed by +6.11%. Follow the TOI chart for real-time price dynamics.

What is the stock ticker of The Oncology Institute, Inc. - Common Stock?

The Oncology Institute, Inc. - Common Stock trades under the ticker TOI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is The Oncology Institute, Inc. - Common Stock stock going up?

TOI has changed by +14.68% over the last week, +20.89% over the last month, and +94.10% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was The Oncology Institute, Inc. - Common Stock net income for the last quarter?

The Oncology Institute, Inc. - Common Stock reported net income of -2.49 M for the last quarter. The previous quarter showed -7.51 M, which means net income changed by +66.81%.

How many employees does The Oncology Institute, Inc. - Common Stock have?

As of the latest available data, The Oncology Institute, Inc. - Common Stock has 641 employees. Workforce size can provide additional context about the company's scale and operations.

What is The Oncology Institute, Inc. - Common Stock EBITDA?

The Oncology Institute, Inc. - Common Stock EBITDA is -33.11 M, and its EBITDA margin is -22.46%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy The Oncology Institute, Inc. - Common Stock stock?

You can buy The Oncology Institute, Inc. - Common Stock (TOI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in The Oncology Institute, Inc. - Common Stock stock?

Investing in The Oncology Institute, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TOI chart and related analysis on metatrader.com as part of your research.

News